Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus

NCT03332836 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped Sopnsor decision

Conditions

Type 2 Diabetes Mellitus

Interventions

BIOLOGICAL: HM12460A

Sponsor

Hanmi Pharmaceutical Company Limited